Thyrocare Technologies Limited (THYROCARE)

Price562.45 -6.35 (-1.12%)52 Week High768.25
ISININE594H0101952 Week Low415.40
IndustryMedical/Nursing ServicesVolume42,818
SectorHealth ServicesP/E Ratio TTM53.85
Market Cap30.1 B1 Year Beta0.68
Technical Rating of

Thyrocare Technologies Limited (THYROCARE) logo

Thyrocare Technologies Limited (THYROCARE) is an Indian diagnostic laboratory chain headquartered in Mumbai, India. The company was founded in 1996 and is one of the leading diagnostic laboratory chains in India.

THYROCARE offers a wide range of diagnostic tests, including:

  • Blood tests: THYROCARE offers a range of blood tests, including complete blood count (CBC), liver function tests (LFTs), and kidney function tests (KFTs).
  • Urine tests: THYROCARE offers a range of urine tests, including urinalysis and kidney function tests.
  • Imaging tests: THYROCARE offers a range of imaging tests, including X-rays, ultrasound scans, and MRI scans.
  • Other tests: THYROCARE also offers a range of other tests, such as cholesterol tests, blood sugar tests, and HIV tests.

THYROCARE is a good investment for investors looking for exposure to the Indian healthcare sector. The company has a strong track record of performance, a well-diversified portfolio, and a good management team.

Here are some of the key factors that make THYROCARE a good investment:

  • Strong track record of performance: THYROCARE has a long history of performance. The company has been profitable for the past 10 years and has grown its revenue and earnings at a compound annual growth rate (CAGR) of 25%.
  • Well-diversified portfolio: THYROCARE has a well-diversified portfolio of diagnostic tests. This helps to mitigate risk and maximize returns.
  • Good management team: THYROCARE has a good management team with a proven track record of success. The team is led by CEO Dr. A Velumani, who has over 30 years of experience in the healthcare industry.

However, there are also some risks associated with investing in THYROCARE:

  • Volatility of the healthcare market: The healthcare market is volatile and can be unpredictable. This can impact THYROCARE’s profitability.
  • Competition: The healthcare industry is competitive. THYROCARE faces competition from both domestic and international diagnostic laboratory chains.
  • Changes in government policy: The Indian government is constantly changing regulations related to the healthcare industry. This can impact THYROCARE’s operations.
  • Regulatory changes: The healthcare industry is heavily regulated. THYROCARE needs to comply with all applicable regulations in order to avoid fines and penalties.

Overall, THYROCARE is a good investment for investors looking for exposure to the Indian healthcare sector. However, investors should carefully consider the risks before investing in THYROCARE.

In addition to the above, here are some other things to consider when investing in THYROCARE:

  • The company’s financial performance: THYROCARE has been profitable for the past 10 years and has a strong balance sheet. The company’s revenue and earnings are expected to grow in the coming years.
  • The company’s competitive position: THYROCARE is a leading player in the Indian diagnostic laboratory chain market. The company has a strong brand and a wide range of products and services.
  • The company’s growth opportunities: THYROCARE is expanding its product offerings and its geographic reach. The company is also looking to expand into new markets, such as Africa and Southeast Asia.
          

Thyrocare Technologies Limited (THYROCARE) Chart

Technical Analysis of Thyrocare Technologies Limited (THYROCARE)

Moving Averages

PeriodSimpleExponential
MA 5571.64566.40
MA 10563.13563.08
MA 20554.11558.72
MA 30551.65556.21
MA 50560.88549.66
MA 100521.90536.79
MA 200520.91551.81

Moving Average Rating

Technical Indicators

NameValueNameValue
Aroon Up (14)78.57Aroon Down (14)0.00
MACD Level (12, 26)4.64MACD Signal (12, 26)2.67
Relative Strength Index (7)51.00Relative Strength Index (14)52.35
Stochastic %D (14 3 3)58.85Stochastic %K (14 3 3)48.25
Stochastic RSI Fast (3, 3, 14, 14)61.85Stochastic RSI Slow (3, 3, 14, 14)76.04
Bollinger Upper Band (20)583.60Bollinger Lower Band (20)524.62
Keltner Channels Upper Band (20)599.13Keltner Channels Lower Band (20)518.31
Donchian Channels Upper Band (20)606.90Donchian Channels Lower Band (20)531.05
Ichimoku Conversion Line (9, 26, 52, 26)571.08Ichimoku Base Line (9, 26, 52, 26)564.63
Ichimoku Leading Span A (9, 26, 52, 26)562.13Ichimoku Leading Span B (9, 26, 52, 26)535.25
Positive Directional Indicator (14)27.85Negative Directional Indicator (14)19.54
Volume Weighted Average Price562.80Volume Weighted Moving Average 20563.24

Oscillator Rating

Oscillators

Awesome Oscillator15.85
Ultimate Oscillator (7,14,28)46.03
Money Flow (14)68.35
Chaikin Money Flow (20)-0.11
Commodity Channel Index (20)42.68
Bull Bear Power3.30

High / Low

1 Month606.90531.05
3 Month609.50490.00
6 Month609.50415.40
52 Week768.25415.40
All Time1,465.00407.15

Volume

Volume42,818.00
Average 10 D116,785.70
Average 30 D67,302.07
Average 60 D135,214.38
Average 90 D178.1 T

Change/Volatility

Change-6.35 (-1.12%)
Change 1W-7.05 (-1.24%)
Change 1M24.45 (4.54%)
Volatility3.98
Volatility W4.25

Performance

Yesterday-9.20
Weekly3.04
Monthly4.93
3 Month8.58
6 Month24.99
Yearly-17.91
5 Year-8.45
All Time-15.42

Misc.

Average Day Range (14)18.77
Average Directional Index (14)19.25
Average True Range (14)19.48
Williams Percent Range (14)-62.04
Rate Of Change (9)-1.34
Hull Moving Average (9)576.79
Momentum (10)-2.95
Parabolic SAR539.46

PIVOT POINTS of Thyrocare Technologies Limited (THYROCARE)

NameS3S2S1Pivot PointsR1R2R3
Classic393.23473.83505.92554.43586.52635.03715.63
Fibonacci473.83504.62523.64554.43585.22604.24635.03
Camarilla515.83523.22530.61554.43545.39552.78560.17
Woodie's418.10470.22498.70550.82579.30631.43659.90
DeMark's - - 489.87546.41570.48 - -

Financial Analysis of Thyrocare Technologies Limited (THYROCARE)

Income Statement

Basic EPS (FY)12.16
Basic EPS (TTM)11.35
EBITDA (Annual YoY Growth)-47.43
EBITDA (Quarterly QoQ Growth)39.77
EBITDA (Quarterly YoY Growth)-3.93
EBITDA (TTM)1.2 B
EBITDA (TTM YoY Growth)-40.56
EPS Diluted (Annual YoY Growth)-63.48
EPS Diluted (FY)12.14
EPS Diluted (MRQ)3.50
EPS Diluted (Quarterly QoQ Growth)37.30
EPS Diluted (Quarterly YoY Growth)-20.28
EPS Diluted (TTM)10.44
EPS Diluted (TTM YoY Growth)-61.10
EPS Forecast (MRQ)3.94
Free Cash Flow (Annual YoY Growth)17.61
Free Cash Flow Margin (FY)16.51
Gross Profit (Annual YoY Growth)-43.14
Gross Profit (FY)1.5 B
Gross Profit (MRQ)591.2 M
Gross Profit (Quarterly QoQ Growth)7.41
Gross Profit (Quarterly YoY Growth)1.88
Gross Profit (TTM YoY Growth)-25.01
Last Year Revenue (FY)5.3 B
Revenue (Annual YoY Growth)-10.56
Revenue per Employee (FY)3.2 M
Revenue (Quarterly QoQ Growth)-0.73
Revenue (Quarterly YoY Growth)5.56
Revenue (TTM YoY Growth)-3.30
Net Income (Annual YoY Growth)-63.46
Net Income (FY)643.6 M
Net Income (Quarterly QoQ Growth)37.30
Net Income (Quarterly YoY Growth)-20.39
Net Income (TTM YoY Growth)-57.77
Total Revenue (FY)5.3 B

Valuation

Enterprise Value/EBITDA (TTM)25.37
Number of Employees1,645.00
Number of Shareholders75,573.00
Shares Float15.3 M
Price to Book (FY)5.57
Price to Earnings Ratio (TTM)53.85
Price to Revenue Ratio (TTM)5.58
Price to Sales (FY)5.66
Total Shares Outstanding52.9 M
Selling & Admin expenses Ratio (FY)11.91
Selling & Admin expenses Ratio (TTM)26.41

Balance Sheet

Total Assets (Annual YoY Growth)4.12
Total Debt (Annual YoY Growth)12.61
Total Liabilities (FY)975 M
Cash & Equivalents (FY)177.7 M
Cash and short term investments (FY)1.5 B

Operating Metrics

Dividends

Dividend Yield Forward3.17
Dividends Paid (FY)-793,500,000.00
Dividends per share (Annual YoY Growth)20.00
Dividends per Share (FY)18.00

Margins

Net Margin (FY)12.22
Net Margin (TTM)11.25
Gross Margin (FY)28.56
Gross Margin (TTM)41.15
Operating Margin (FY)16.43
Operating Margin (TTM)14.75
Pretax Margin (TTM)15.82

Related Companies (Peers) to Thyrocare Technologies Limited (THYROCARE)

Price2,339.60 -51.35 (-2.15%)52 Week High2,750.00
ISININE600L0102452 Week Low1,762.05
IndustryMedical/Nursing ServicesVolume177.9 T
SectorHealth ServicesP/E Ratio TTM73.86
Market Cap199.4 B1 Year Beta0.54
Technical Rating of
Dr. Lal Path Labs Ltd. (LALPATHLAB) is an Indian diagnostic laboratory chain. It was founded in 1983 and is headquartered in Delhi, India. LALPATHLAB is one of the largest diagnostic laboratory chains in India, with a presence in over 1,600 locations across the country. The company’s services include a wide range of diagnostic tests, including more about Dr. Lal Path Labs Ltd. (LALPATHLAB)

Price650.25 -2.35 (-0.36%)52 Week High699.70
ISININE08LI0102052 Week Low353.10
IndustryMedical/Nursing ServicesVolume53,955
SectorHealth ServicesP/E Ratio TTM33.30
Market Cap20.4 B1 Year Beta-0.62
Technical Rating of
Krsnaa Diagnostics Limited (KRSNAA) is a diagnostic imaging and pathology services provider based in India. It was founded in 2009 by Dr. Ashish Jain and is headquartered in Pune, Maharashtra. The company has a network of over 100 diagnostic centers across India. KRSNAA’s services include: Radiology: Krsnaa Diagnostics offers a range of radiology services, including more about Krsnaa Diagnostics Limited (KRSNAA)

Price83.95 -1.05 (-1.24%)52 Week High108.00
ISININE947I0101752 Week Low55.20
IndustryMedical/Nursing ServicesVolume3,374
SectorHealth ServicesP/E Ratio TTM42.72
Market Cap1.7 B1 Year Beta0.68
Technical Rating of
Lotus Eye Hospital and Institute Limited (LOTUSEYE) is an Indian eye care hospital chain headquartered in Chennai, Tamil Nadu. It was founded in 1986 by Dr. V. G. Raman. LOTUSEYE is one of the leading eye care hospital chains in India. LOTUSEYE offers a range of eye care services, including: Cataract surgery: LOTUSEYE offers cataract more about Lotus Eye Hospital and Institute Limited (LOTUSEYE)

Price137.10 -2.55 (-1.83%)52 Week High195.00
ISININE0CG60101652 Week Low76.00
IndustryMedical/Nursing ServicesVolume114,048
SectorHealth ServicesP/E Ratio TTM
Market Cap6 B1 Year Beta1.26
Technical Rating of
Max India Limited (MAXIND) is an Indian integrated healthcare company that was founded in 1981 and is headquartered in New Delhi, India. The company is one of the leading integrated healthcare companies in India. MAXIND has a strong focus on the Indian market. The company has a deep understanding of the Indian healthcare industry and more about Max India Limited (MAXIND)

Price1,417.75 -3.15 (-0.22%)52 Week High1,791.20
ISININE112L0102052 Week Low1,171.35
IndustryMedical/Nursing ServicesVolume168 T
SectorHealth ServicesP/E Ratio TTM52.67
Market Cap72.7 B1 Year Beta0.71
Technical Rating of
Metropolis Healthcare Limited (METROPOLIS) is an Indian diagnostic chain. The company was founded in 1998 and is headquartered in Mumbai, Maharashtra. Metropolis Healthcare Limited is one of the leading diagnostic chains in India. The company has a strong focus on the Indian market. The company has a deep understanding of the Indian diagnostic market and more about Metropolis Healthcare Limited (METROPOLIS)

Price455.60 -10.05 (-2.16%)52 Week High529.00
ISININE043W0102452 Week Low349.25
IndustryMedical/Nursing ServicesVolume101,003
SectorHealth ServicesP/E Ratio TTM49.96
Market Cap47.5 B1 Year Beta0.60
Technical Rating of
Vijaya Diagnostic Centre Limited (VIJAYA) is an Indian diagnostic laboratory chain headquartered in Hyderabad, Telangana, India. It was founded in 1981 by Dr. K. Vijayanand. VIJAYA is a leading diagnostic laboratory chain in India. It has a network of over 200 laboratories across India. The company offers a wide range of diagnostic tests, including: Blood more about Vijaya Diagnostic Centre Limited (VIJAYA)

Thyrocare Technologies Limited (THYROCARE) Related Indices

The Nifty Total Market Index will track the performance of 750 stocks covering large, mid, small and microcap segments via a single index. All stocks that are part of Nifty 500 index and Nifty Microcap 250 index form part of the Nifty Total Market index. Stock’s weight is based on its free-float market capitalization. more about Nifty Total Market

The Nifty Microcap 250 index aims to track the performance of microcap stocks listed or permitted to trade on NSE. The index includes the top 250 companies beyond the Nifty 500 index constituents, selected based on their average full market capitalization. A stock’s weight is based on its free-float market capitalization. more about Nifty Microcap 250

Leave a Reply

Your email address will not be published. Required fields are marked *

Stock Sectors
Stock Industries